NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
Analyzing Nanoviricides' Shift to RSV Treatments With Proactive Healthcare Analyst Dr. John Savin | NYSE-A:NNVC
Lethally RSV Infected Animals Orally Treated With NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NV-387, A Broad-Spectrum Antiviral with Strong Activity Against RSV, Influenza A, Coronaviruses, Others SHELTON, CT / ACCESSWIRE / May 20, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company
NanoViricides Reports Strong Antiviral Activity of NV-387 Against RSV | NYSE-A:NNVC
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million. SINTX Techs (NASDAQ:SINT) sha
Nanoviricides | 10-Q: Quarterly report
NYSE American New 52-Week Highs And Lows
New Highs 5 COMPANY SYMBOL HIGH VOLUME ------- ------ ---- ------ Actinium Pharmaceuticals ATNM 9.99 307,312 Am
A Novel Broad-Spectrum Antiviral With Activity Against RSV
Complete Survival of Animals Lethally Infected into Lungs with RSV Achieved Upon NV-387 Oral Treatment SHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. , a global
NanoViricides Unveils New Data Showing Lead Drug Asset's Strong Activity Against RSV | NYSE-A:NNVC
NanoViricides CEO Discusses NV-387's Broad-spectrum Antiviral Potential | NYSE-A:NNVC
NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City
SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. , a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's
NanoViricides to Showcase Lead Drug Asset's Progress at EF Hutton Annual Global Conference | NYSE-A:NNVC
NanoViricides Reports Research With NV-387 Showing Promising Results Against Multiple Viruses | NYSE-A:NNVC
NanoViricides Reports Breakthrough in Treating Airborne Viruses, Boosting Lifespan in Infected Mice
NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral activity spectrum of NV-387 includes activity against or
Express News | NanoViricides Inc: NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission
Express News | NanoViricides Inc: Ultra-Broad Antiviral Activity Spectrum of NV-387 Includes Activity Against Orthopoxvirus Family (Smallpox/Mpox)
A Novel Broad-Spectrum Antiviral With Activity Against Smallpox/Mpox
NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 8, 2024 / NanoViricides, Inc. (NYSE Ameri
NanoViricides Says Lead Asset Shows Antiviral Activity Against Smallpox and Mpox | NYSE-A:NNVC
NanoViricides, TC BioPharm, Holdco Nuvo Among Healthcare Movers
12 Health Care Stocks Moving In Monday's Intraday Session
GainersNRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 39.5% to $2.93 during Monday's regular session. The company's market cap stands at $30.9 million. TC BioPharm (Holdings) (NASDAQ:TCBP) stoc